185 filings
Page 6 of 10
8-K
4zc70e0ougt7z5mbbd51
19 Oct 20
Replimune Appoints Tanya Lewis to the Board of Directors
5:13pm
8-K
i2d4zkwo
14 Oct 20
Replimune Announces Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
5:14pm
8-K
oc9t4 3t16
10 Sep 20
Submission of Matters to a Vote of Security Holders
4:01pm
EFFECT
uezh9xg ob0a183o
27 Aug 20
Notice of effectiveness
12:15am
8-K/A
ymftk26pesy5rv9x
25 Aug 20
Entry into a Material Definitive Agreement
4:45pm
CORRESP
nfn319 cal
25 Aug 20
Correspondence with SEC
12:00am
UPLOAD
polmk
13 Aug 20
Letter from SEC
12:00am
8-K
zrsepf7l
11 Aug 20
Entry into a Material Definitive Agreement
5:16pm
8-K
53qbyl
7 Aug 20
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
4:25pm
8-K
a7ispvm4cq8m5
7 Aug 20
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
4:24pm
8-K
fhg9iyrq1b
22 Jul 20
Departure of Directors or Certain Officers
8:12am
8-K
0gdcth 52
1 Jul 20
Other Events
6:03am
8-K
zik1jh 77rg0l0j
10 Jun 20
Replimune Announces Proposed Public Offering
4:27pm
424B5
15gx1 19k
10 Jun 20
Prospectus supplement for primary offering
4:04pm
424B5
btuaewg6 0j8e8z
8 Jun 20
Prospectus supplement for primary offering
4:44pm
8-K
rgedgg
8 Jun 20
Other Events
4:04pm